(4-hydroxy-3-iodophenyl)(2-methylbenzofuran-3-yl)methanone

ID: ALA4287926

PubChem CID: 74220778

Max Phase: Preclinical

Molecular Formula: C16H11IO3

Molecular Weight: 378.17

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1oc2ccccc2c1C(=O)c1ccc(O)c(I)c1

Standard InChI:  InChI=1S/C16H11IO3/c1-9-15(11-4-2-3-5-14(11)20-9)16(19)10-6-7-13(18)12(17)8-10/h2-8,18H,1H3

Standard InChI Key:  BCZJNMTWGUDJGX-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 20 22  0  0  0  0  0  0  0  0999 V2000
   13.0324  -13.3681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0312  -14.1876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7393  -14.5966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4489  -14.1871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4461  -13.3645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7375  -12.9592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3232  -14.5956    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.1523  -12.9532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8615  -13.3591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1492  -12.1360    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.1551  -13.6285    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.6059  -13.0234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7723  -12.2233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7491  -14.3378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9538  -14.1678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4109  -14.7708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6621  -15.5440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4612  -15.7109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0006  -15.1065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7391  -15.4137    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  2  7  1  0
  5  8  1  0
  8  9  1  0
  8 10  2  0
  9 15  1  0
 14 11  1  0
 11 12  1  0
 12  9  2  0
 12 13  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
  3 20  1  0
M  END

Associated Targets(Human)

EYA3 Tbio Eyes absent homolog 3 (40 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HUVEC (11049 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Aorta (52 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 378.17Molecular Weight (Monoisotopic): 377.9753AlogP: 4.28#Rotatable Bonds: 2
Polar Surface Area: 50.44Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 6.70CX Basic pKa: CX LogP: 4.42CX LogD: 3.65
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.54Np Likeness Score: -0.23

References

1.  (2016)  Use of small molecule inhibitors targeting eya tyrosine phosphatase, 
2.  (2017)  Use of small molecule inhibitors targeting EYA tyrosine phosphatase, 

Source